Insights into Ironwood Pharmaceuticals's Upcoming Earnings
Ironwood Pharmaceuticals, Inc. Class A IRWD | 3.46 | -1.98% |
Ironwood Pharmaceuticals (NASDAQ:IRWD) is preparing to release its quarterly earnings on Wednesday, 2026-02-25. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Ironwood Pharmaceuticals to report an earnings per share (EPS) of $0.01.
Anticipation surrounds Ironwood Pharmaceuticals's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Historical Earnings Performance
The company's EPS beat by $0.13 in the last quarter, leading to a 14.23% increase in the share price on the following day.
Here's a look at Ironwood Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.11 | 0.02 | -0.01 | 0.08 |
| EPS Actual | 0.24 | 0.14 | -0.14 | 0.02 |
| Price Change % | 14.00 | 2.00 | -12.00 | -1.00 |
Market Performance of Ironwood Pharmaceuticals's Stock
Shares of Ironwood Pharmaceuticals were trading at $3.75 as of February 23. Over the last 52-week period, shares are up 114.04%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Ironwood Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.